Ignite Creation Date:
2025-12-24 @ 6:48 PM
Ignite Modification Date:
2026-05-22 @ 11:49 AM
Study NCT ID:
NCT00730457
Status:
COMPLETED
Last Update Posted:
2014-09-23
First Post:
2008-08-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Safety and Immunogenicity Study in Healthy Adults of VAX125, a Recombinant HA-flagellin Influenza Vaccine
Sponsor:
VaxInnate Corporation
Organization: